A METHOD OF PREDICTING CLINICAL OUTCOMES FOR MELANOMA PATIENTS USING CIRCULATING MELANOMA CELLS IN BLOOD

Title:

A METHOD OF PREDICTING CLINICAL OUTCOMES FOR MELANOMA PATIENTS USING CIRCULATING MELANOMA CELLS IN BLOOD

Document Type and Number:

WIPO Patent Application WO/2011/156468

Kind Code:

A8

Abstract:

The present invention provides an automated method for capturing and detecting circulating melanoma cells (CMC's) in the blood of patients with melanoma. The absolute number of circulating melanoma cells detected in the peripheral blood tumor load is, in part, a factor in prediction of survival, time to progression, and response to therapy.

Inventors:

RAO GALLA CHANDRA (US)
CONNELLY MARK C (US)

Application Number:

PCT/US2011/039596

Publication Date:

December 20, 2012

Filing Date:

June 08, 2011

Export Citation:

Click for automatic bibliography generation Help

Assignee:

VERIDEX LLC (US)
RAO GALLA CHANDRA (US)
CONNELLY MARK C (US)

International Classes:

G01N33/574

Attorney, Agent or Firm:

JOHNSON, Philip, S. et al. (1 Johnson & Johnson PlazaNew Brunswick, NJ, US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHODS OF DETECTING RESIDUAL AMOUNTS OF POLYMERS USED IN THE PURIFICATION OF BIOMOLECULES

Next Patent: METHOD FOR TREATING AND SEALING PIEZOELECRIC TUNING FORKS